Stay updated on CDX-0159 in Prurigo Nodularis Clinical Trial
Sign up to get notified when there's something new on the CDX-0159 in Prurigo Nodularis Clinical Trial page.

Latest updates to the CDX-0159 in Prurigo Nodularis Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now displays the ClinicalTrials.gov record for the CDX-0159 study in patients with prurigo nodularis, including its eligibility criteria, treatment arms, measured outcomes, and participating locations. The record indicates that the study is completed and is no longer recruiting.SummaryDifference47%

- Check19 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check26 days agoChange DetectedA banner announces NIH’s website transition and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check33 days agoChange DetectedThe footer’s site revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check40 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1. The page displays a 403 Forbidden response instead of the study record.SummaryDifference0.2%

- Check61 days agoChange DetectedThe study record page now displays a 403 Forbidden error, replacing the full set of trial details with an error screen.SummaryDifference17%

Stay in the know with updates to CDX-0159 in Prurigo Nodularis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CDX-0159 in Prurigo Nodularis Clinical Trial page.